← back to search

Olivier Garraud

Université Claude Bernard Lyon 1 · FR
Area of research
Biochemistry · Management of Technology and Innovation
Research interest
Research interests include Platelet, Immunology, Medicine, Cell biology, Biology, and Immune system.
h-index
citations
4,170
works
50
NIH funding
primary concept
email

Recent publications

Platelets as Key Factors in Inflammation: Focus on CD40L/CD40
Frontiers in Immunology 2022cited by 143position: middledoi
Platelet transfusion in adults: An update
Transfusion Clinique et Biologique 2022cited by 42position: firstdoi
Platelet Innate Immune Receptors and TLRs: A Double-Edged Sword
International Journal of Molecular Sciences 2021cited by 73position: middledoi
Effects and Side Effects of Platelet Transfusion
Hämostaseologie 2021cited by 22position: middledoi
Review of indications for immunoglobulin (IG) use: Narrowing the gap between supply and demand
Transfusion Clinique et Biologique 2020cited by 52position: middledoi
Platelet Inflammatory Response to Stress
Frontiers in Immunology 2019cited by 130position: middledoi
Platelet‐derived extracellular vesicles convey mitochondrial DAMPs in platelet concentrates and their levels are associated with adverse reactions
Transfusion 2019cited by 88position: middledoi
Evidence of CD40L/CD40 pathway involvement in experimental transfusion-related acute lung injury
Scientific Reports 2019cited by 33position: middledoi
Immunological Features in the Process of Blood Platelet-Induced Alloimmunisation, with a Focus on Platelet Component Transfusion
Diseases 2019cited by 17position: firstdoi
The Non-Hemostatic Aspects of Transfused Platelets
Frontiers in Medicine 2018cited by 69position: middledoi
Platelet toll-like receptors are crucial sensors of infectious danger moieties
Platelets 2018cited by 38position: middledoi
Transfusion-associated hazards: A revisit of their presentation
Transfusion Clinique et Biologique 2018cited by 38position: firstdoi
Pathogen inactivation/reduction technologies for platelet transfusion: Where do we stand?
Transfusion Clinique et Biologique 2018cited by 18position: firstdoi
Wound healing: time to look for intelligent, ‘natural’ immunological approaches?
BMC Immunology 2017cited by 89position: firstdoi
Platelet soluble CD40-ligand level is associated with transfusion adverse reactions in a mixed threshold-and-hit model
Blood 2017cited by 43position: lastdoi
NF-κB Links TLR2 and PAR1 to Soluble Immunomodulator Factor Secretion in Human Platelets
Frontiers in Immunology 2017cited by 28position: middledoi
Bee Venom Accelerates Wound Healing in Diabetic Mice by Suppressing Activating Transcription Factor‐3 (ATF‐3) and Inducible Nitric Oxide Synthase (iNOS)‐Mediated Oxidative Stress and Recruiting Bone Marrow‐Derived Endothelial Progenitor Cells
Journal of Cellular Physiology 2016cited by 82position: lastdoi
Transfusion as an Inflammation Hit: Knowns and Unknowns
Frontiers in Immunology 2016cited by 74position: firstdoi
Transfusion-related acute lung injury: transfusion, platelets and biological response modifiers
Expert Review of Hematology 2016cited by 40position: middledoi
Use of convalescent plasma in Ebola virus infection
Transfusion and Apheresis Science 2016cited by 34position: firstdoi
Levels of human platelet-derived soluble CD40 ligand depend on haplotypes of CD40LG-CD40-ITGA2
Scientific Reports 2016cited by 29position: middledoi
Properties of donated red blood cell components from patients with hereditary hemochromatosis
Transfusion 2016cited by 17position: middledoi
Platelets and Infections – Complex Interactions with Bacteria
Frontiers in Immunology 2015cited by 231position: lastdoi
Topical Application of Propolis Enhances Cutaneous Wound Healing by Promoting TGF-Beta/Smad-Mediated Collagen Production in a Streptozotocin-Induced Type I Diabetic Mouse Model
Cellular Physiology and Biochemistry 2015cited by 143position: lastdoi
Are Platelets Cells? And if Yes, are They Immune Cells?
Frontiers in Immunology 2015cited by 140position: firstdoi
An overview of the role of microparticles/microvesicles in blood components: Are they clinically beneficial or harmful?
Transfusion and Apheresis Science 2015cited by 113position: middledoi
Platelet Transfusion – The New Immunology of an Old Therapy
Frontiers in Immunology 2015cited by 102position: middledoi
Immunogenicity of infectious pathogens and vaccine antigens
BMC Immunology 2015cited by 77position: lastdoi
Human platelets and their capacity of binding viruses: meaning and challenges?
BMC Immunology 2015cited by 76position: lastdoi
The role of microparticles in inflammation and transfusion: A concise review
Transfusion and Apheresis Science 2015cited by 75position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Fabrice Cognasse · Georges Friedel Laboratory35 papers (2012–2022)Hind Hamzeh‐Cognasse · Inserm28 papers (2012–2022)Bruno Pozzetto · Université Claude Bernard Lyon 116 papers (2012–2018)Sandrine Laradi · Université Claude Bernard Lyon 115 papers (2014–2021)Charles Antoine Arthaud · Inserm10 papers (2012–2022)Marie‐Ange Eyraud · Inserm9 papers (2012–2022)Sofiane Tariket · Université Claude Bernard Lyon 17 papers (2014–2019)Gamal Badr · Al-Azhar University7 papers (2012–2017)Caroline Sut · Université Claude Bernard Lyon 17 papers (2014–2019)Chaker Aloui · Université Claude Bernard Lyon 16 papers (2014–2018)Pauline Damien · Université Claude Bernard Lyon 15 papers (2012–2017)P. Berthelot · Université Claude Bernard Lyon 15 papers (2018–2021) · 4 papers (2013–2014) · 4 papers (2015–2017)Thomas Bourlet · Université Claude Bernard Lyon 14 papers (2018–2019)Kim Nguyen · University of Padua4 papers (2013–2015)Neil Blumberg · University of Rochester Medical Center3 papers (2015–2017)Patrick Mismetti · Université Claude Bernard Lyon 13 papers (2021–2022)Antoine Prigent · Université Claude Bernard Lyon 13 papers (2014–2016)Jocelyne Fagan · Université Claude Bernard Lyon 13 papers (2015–2021)